In previous studies, osteopontin (SPP1) was investigated in the urine of nephrolithiasis [101], Alzheimer’s disease patients [102], and in cancer patients presenting cisplatin-induced nephrotoxicity [103], and was found to provide diagnostic value. Here, SPP1 is linked to early-onset autosomal dominant Alzheimer disease.